Phase 2 study of Pembro + Lenvatinib + Belzutifan in Solid Tumors

An Open-label, Multicenter, Phase 2 Study to Evaluate the Efficacy and Safety of Pembrolizumab Plus Lenvatinib in Combination With Belzutifan in Multiple Solid Tumors

Disease Types: Gastrointestinal

Available at: Alleghany, Blacksburg, Roanoke, Salem, Wytheville

An Open-label, Multicenter, Phase 2 Study to Evaluate the Efficacy and Safety of Pembrolizumab Plus Lenvatinib in Combination With Belzutifan in Multiple Solid Tumors

For More Information:

https://clinicaltrials.gov/study/NCT04976634?term=An%20Open-label,%20Multicenter,%20Phase%202%20Study%20to%20Evaluate%20the%20Efficacy%20and%20Safety%20of%20Pembrolizumab%20Plus%20Lenvatinib%20in%20Combination%20With%20Belzutifan%20in%20Multiple%20Solid%20Tumors&rank=1